ReviewJournal of clinical hypertension (Greenwich, Conn.)2009

The risks and benefits of initial irbesartan/hydrochlorothiazide combination therapy in patients with severe hypertension.

Pablo Lapuerta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.